Search

Issue
Title
Authors
The efficacy and safety of eculizumab biosimilar in patients with paroxysmal nocturnal hemoglobinuria. Results of a phase III randomized open-label comparative clinical trial
Kulagin A.D., Bakirov B.A., Davydkin I.L., Elykomov I.V., Konstantinova T.S., Korobkin A.V., Kosinova M.V., Mazurov V.I., Minaeva N.V., Proidakov A.V., Ptushkin V.V., Shatokhin Y.V., Lin'kova Y.N., Zinkina-Orikhan A.V., Morozova M.A.
Loss of response and frequency of adverse events in patients with ulcerative colitis and Crohn’s disease when switching from the original infliximab to its biosimilars
Knyazev O.V., Zvyaglova M.Y., Kagramanova A.V., Li I.A., Sabelnikova E.A., Lishchinskaya A.A., Kulakov D.S., Parfenov A.I.
Evaluation of efficacy and comparative frequency of adverse events in patients with ulcerative colitis receiving the original infliximab and its biosimilar. One year of observation
Knyazev O.V., Shkurko T.V., Kagramanova A.V., Lishchinskaya A.A., Zvyaglova M.Y., Korneeva I.A., Babayan A.F., Parfenov A.I.
The role of laboratory biomarkers in monitoring of rituximab biosimilar therapy (Acellbia, “BIOCAD”) in patients with rheumatoid arthritis
Avdeeva A.S., Cherkasova M.V., Kusevich D.A., Rybakova V.V., Artyuhov A.S., Dashinimaev E.B., Chichasova N.V., Nasonov E.L.
1 - 4 of 4 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies